271 related articles for article (PubMed ID: 12465153)
1. Increased circulating concentrations of the counteradhesive proteins SPARC and thrombospondin-1 in systemic sclerosis (scleroderma). Relationship to platelet and endothelial cell activation.
Macko RF; Gelber AC; Young BA; Lowitt MH; White B; Wigley FM; Goldblum SE
J Rheumatol; 2002 Dec; 29(12):2565-70. PubMed ID: 12465153
[TBL] [Abstract][Full Text] [Related]
2. Platelet activation, endothelial cell dysfunction in the absence of anticardiolipin antibodies in systemic sclerosis.
Lima J; Fonollosa V; Fernández-Cortijo J; Ordi J; Cuenca R; Khamashta MA; Vilardell M; Simeón CP; Picó M
J Rheumatol; 1991 Dec; 18(12):1833-6. PubMed ID: 1839040
[TBL] [Abstract][Full Text] [Related]
3. [Soluble P-selectin - a marker of platelet activation and vessel wall injury: increase of soluble P-selectin in plasma of patients with myocardial infarction, massive atherosclerosis and primary pulmonary hypertension].
Semenov AV; Kogan-Ponomarev MIa; Ruda MIa; Komarov AL; Panchenko EP; Chazova IE; Mazurov AV
Ter Arkh; 2000; 72(4):15-20. PubMed ID: 10833791
[TBL] [Abstract][Full Text] [Related]
4. Effects of oral cyclophosphamide and prednisolone therapy on the endothelial functions and clinical findings in patients with early diffuse systemic sclerosis.
Apras S; Ertenli I; Ozbalkan Z; Kiraz S; Ozturk MA; Haznedaroglu IC; Cobankara V; Pay S; Calguneri M
Arthritis Rheum; 2003 Aug; 48(8):2256-61. PubMed ID: 12905480
[TBL] [Abstract][Full Text] [Related]
5. Neuron specific enolase concentration is increased in serum and decreased in platelets of patients with active systemic sclerosis.
Massabki PS; Silva NP; Lourenço DM; Andrade LE
J Rheumatol; 2003 Dec; 30(12):2606-12. PubMed ID: 14719201
[TBL] [Abstract][Full Text] [Related]
6. [Systemic sclerosis and scleroderma circumscripta--disturbances of selected serum parameters which are responsible for vascular changes and CD34 expression in involved skin].
Dziankowska-Bartkowiak B; Zebrowska A; Wagrowska-Danielewicz M; Kobos J; Waszczykowska E
Przegl Lek; 2009; 66(12):1040-5. PubMed ID: 20514902
[TBL] [Abstract][Full Text] [Related]
7. Beta thromboglobulin and platelet factor 4 in bronchoalveolar lavage fluid of patients with systemic sclerosis.
Kowal-Bielecka O; Kowal K; Lewszuk A; Bodzenta-Lukaszyk A; Walecki J; Sierakowski S
Ann Rheum Dis; 2005 Mar; 64(3):484-6. PubMed ID: 15708900
[TBL] [Abstract][Full Text] [Related]
8. Assessment of vascular function in systemic sclerosis: indications of the development of nitrate tolerance as a result of enhanced endothelial nitric oxide production.
Andersen GN; Mincheva-Nilsson L; Kazzam E; Nyberg G; Klintland N; Petersson AS; Rantapää-Dahlqvist S; Waldenström A; Caidahl K
Arthritis Rheum; 2002 May; 46(5):1324-32. PubMed ID: 12115240
[TBL] [Abstract][Full Text] [Related]
9. Elevated circulating CD40L concentrations in patients with systemic sclerosis.
Komura K; Sato S; Hasegawa M; Fujimoto M; Takehara K
J Rheumatol; 2004 Mar; 31(3):514-9. PubMed ID: 14994397
[TBL] [Abstract][Full Text] [Related]
10. Elevated vascular endothelial growth factor in systemic sclerosis.
Choi JJ; Min DJ; Cho ML; Min SY; Kim SJ; Lee SS; Park KS; Seo YI; Kim WU; Park SH; Cho CS
J Rheumatol; 2003 Jul; 30(7):1529-33. PubMed ID: 12858453
[TBL] [Abstract][Full Text] [Related]
11. Humoral SPARC/osteonectin protein in plasma cell dyscrasias.
Turk N; Kusec R; Jaksic B; Turk Z
Ann Hematol; 2005 May; 84(5):304-10. PubMed ID: 15645230
[TBL] [Abstract][Full Text] [Related]
12. Circulating microparticles and plasma levels of soluble E- and P-selectins in patients with systemic sclerosis.
Iversen LV; Østergaard O; Ullman S; Nielsen CT; Halberg P; Karlsmark T; Heegaard NH; Jacobsen S
Scand J Rheumatol; 2013; 42(6):473-82. PubMed ID: 24016306
[TBL] [Abstract][Full Text] [Related]
13. Plasma D-dimer concentration in patients with systemic sclerosis.
Marie I; Borg JY; Hellot MF; Levesque H
Br J Dermatol; 2008 Feb; 158(2):392-5. PubMed ID: 18028493
[TBL] [Abstract][Full Text] [Related]
14. Circulating thrombopoietin in systemic sclerosis.
Ertenli I; Kiraz S; Ertürk H; Haznedaroglu IC; Celik I; Calgüneri M; Kirazli S
J Rheumatol; 1999 Sep; 26(9):1939-41. PubMed ID: 10493673
[TBL] [Abstract][Full Text] [Related]
15. Detection of enhanced in vivo platelet alpha-granule release in different patient groups--comparison of beta-thromboglobulin, platelet factor 4 and thrombospondin assays.
Lane DA; Ireland H; Wolff S; Ranasinghe E; Dawes J
Thromb Haemost; 1984 Oct; 52(2):183-7. PubMed ID: 6084323
[TBL] [Abstract][Full Text] [Related]
16. The origin of P-selectin as a circulating plasma protein.
Fijnheer R; Frijns CJ; Korteweg J; Rommes H; Peters JH; Sixma JJ; Nieuwenhuis HK
Thromb Haemost; 1997 Jun; 77(6):1081-5. PubMed ID: 9241736
[TBL] [Abstract][Full Text] [Related]
17. Soluble P-selectin in atherosclerosis: a comparison with endothelial cell and platelet markers.
Blann AD; Lip GY; Beevers DG; McCollum CN
Thromb Haemost; 1997 Jun; 77(6):1077-80. PubMed ID: 9241735
[TBL] [Abstract][Full Text] [Related]
18. Increased releasability of platelet products and reduced heparin-induced platelet factor 4 release from endothelial cells in bronchial asthma.
Yasuba H; Chihara J; Kino T; Satake N; Oshima S
J Lipid Mediat; 1991; 4(1):5-21. PubMed ID: 1832572
[TBL] [Abstract][Full Text] [Related]
19. Association of novel polymorphisms with the expression of SPARC in normal fibroblasts and with susceptibility to scleroderma.
Zhou X; Tan FK; Reveille JD; Wallis D; Milewicz DM; Ahn C; Wang A; Arnett FC
Arthritis Rheum; 2002 Nov; 46(11):2990-9. PubMed ID: 12428242
[TBL] [Abstract][Full Text] [Related]
20. Simvastatin reduces endothelial activation and damage but is partially ineffective in inducing endothelial repair in systemic sclerosis.
Del Papa N; Cortiana M; Vitali C; Silvestris I; Maglione W; Comina DP; Lucchi T; Cortelezzi A
J Rheumatol; 2008 Jul; 35(7):1323-8. PubMed ID: 18528965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
